Collaboration of human phagocytes with LY 303366 for antifungal activity against Aspergillus fumigatus

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 4, 1999, Pages 491-496

  Brummer, Elmer ^a,b,c   Chauhan, Sharda D ^b   Stevens, David A ^a,b,c  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; ENZYME INHIBITOR; GLUCAN SYNTHASE; SODIUM;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BIOASSAY; COCULTURE; CORRELATION FUNCTION; EFFECTOR CELL; FUNGUS SPORE; GROWTH INHIBITION; HUMAN; HUMAN CELL; METABOLISM; MONOCYTE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; SPORE GERMINATION;

EID: 0032961223     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.4.491     Document Type: Article

References (8)

1. Rennie, R., Sand, C. & Smith, S. (1996). In vitro activity of antifungal agents LY 303366 against Candida species, and other yeasts and Aspergillus species. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract F45, p. 107. American Society for Microbiology, Washington, DC.
2. Stevens, D. A., Martinez, M. & Devine, M. J. (1996). Antifungal activity of LY303366, an echinocandin beta glucan synthase inhibitor. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract F46, p. 107. American Society for Microbiology, Washington, DC.
3. Meshulam, T., Levitz, S. M., Christin, L. & Diamond, R. D. (1995). A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxamide (XTT). Journal of Infectious Diseases 172, 1153-6.
4. Douglas, S. D., Zuckerman, S. H. & Ackerman, S. K. (1981), Obtaining and culturing human monocytes. In Methods for Studying Mononuclear Phagocytes (Adams, D. O., Edelson, P. J. & Koren, H., Eds), pp. 33-42. Academic Press, New York.
5. Kurtz, M. B., Heath, I. B., Marrinan, J., Dreikorn, S., Onishi, J. & Douglas, C. (1994). Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrobial Agents and Chemotherapy 38, 1480-9.
6. Hanson, L. H. & Stevens, D. A. (1989). Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens. Antimicrobial Agents and Chemotherapy 33, 1391-2.
7. Denning, D. W. & Stevens, D. A. (1991). Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis. Antimicrobial Agents and Chemotherapy 35, 1329-33.
8. Verweij, P. E., Oakley, K. L., Morrisey, J., Morrisey, G. & Denning, D. W. (1998). Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis. Antimicrobial Agents and Chemotherapy 42, 873-8.